# European Organisation for Rare Diseases

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/european-organisation-for-rare-diseases/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 71.3 |
| Citations | 49,283 |
| City | Paris |
| Country | FR |
| Description | European Organisation for Rare Diseases is a research organisation in Paris, FR. OpenAlex records 1,274 works and 49,283 citations for it. 343 researchers list it as their most recent affiliation. |
| Homepage | https://www.eurordis.org |
| OpenAlex ID | https://openalex.org/I1285072804 |
| Region | Île-de-France |
| Researchers | 343 |
| ROR ID | https://ror.org/019w4mg02 |
| Type | nonprofit |
| Works | 1,274 |

## University papers

Showing 12 of 19.

- [Formal Methods for Components and Objects](https://scholariq.org/papers/formal-methods-for-components-and-objects/)
- [Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis](https://scholariq.org/papers/microvascular-covid-19-lung-vessels-obstructive-thromboinflammatory-syndrome/)
- [Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study](https://scholariq.org/papers/efficacy-and-safety-of-tocilizumab-in-severe-covid-19-patients-a-single-centre/)
- [Agent Programming in 3APL](https://scholariq.org/papers/agent-programming-in-3apl/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)
- [Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy](https://scholariq.org/papers/early-predictors-of-clinical-outcomes-of-covid-19-outbreak-in-milan-italy/)
- [Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease](https://scholariq.org/papers/phase-i-ii-trial-of-autologous-stem-cell-transplantation-in-systemic-sclerosis/)
- [Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy](https://scholariq.org/papers/characteristics-treatment-outcomes-and-cause-of-death-of-invasively-ventilated/)
- [Verification of Sequential and Concurrent Programs](https://scholariq.org/papers/verification-of-sequential-and-concurrent-programs/)
- [Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.](https://scholariq.org/papers/outcome-of-69-allogeneic-stem-cell-transplantations-for-fanconi-anemia-using-hla/)
- [A Complete Guide to the Future](https://scholariq.org/papers/a-complete-guide-to-the-future/)
- [Agent Programming with Declarative Goals](https://scholariq.org/papers/agent-programming-with-declarative-goals/)

## University researchers

- [Frank S. de Boer](https://scholariq.org/researchers/frank-s-de-boer/)

## University top topics

Showing 8 of 25.

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Genomics and Rare Diseases](https://scholariq.org/topics/genomics-and-rare-diseases/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.